Market Research Logo

Insulin Delivery Devices - Medical Devices Pipeline Assessment, 2019

Insulin Delivery Devices - Medical Devices Pipeline Assessment, 2019

Insulin Delivery Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Insulin Delivery Devices - Medical Devices Pipeline Assessment, 2019 provides an overview of Insulin Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Insulin Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


  • Introduction
    • Insulin Delivery Devices Overview
  • Products under Development
    • Insulin Delivery Devices - Pipeline Products by Stage of Development
      • Table Figure 1: Insulin Delivery Devices - Pipeline Products by Stage of Development
      • Table Insulin Delivery Devices - Pipeline Products by Stage of Development
    • Insulin Delivery Devices - Pipeline Products by Segment
      • Table Figure 2: Insulin Delivery Devices - Pipeline Products by Segment
      • Table Insulin Delivery Devices - Pipeline Products by Segment
    • Insulin Delivery Devices - Pipeline Products by Territory
      • Table Figure 3: Insulin Delivery Devices - Pipeline Products by Territory
      • Table Insulin Delivery Devices - Pipeline Products by Territory
    • Insulin Delivery Devices - Pipeline Products by Regulatory Path
      • Table Figure 4: Insulin Delivery Devices - Pipeline Products by Regulatory Path
      • Table Insulin Delivery Devices - Pipeline Products by Regulatory Path
    • Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
      • Table Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
    • Insulin Delivery Devices - Ongoing Clinical Trials
      • Table Figure 6: Insulin Delivery Devices - Ongoing Clinical Trials
      • Table Insulin Delivery Devices - Ongoing Clinical Trials
  • Insulin Delivery Devices - Pipeline Products under Development by Companies
    • Insulin Delivery Devices Companies - Pipeline Products by Stage of Development
      • Table Insulin Delivery Devices Companies - Pipeline Products by Stage of Development
    • Insulin Delivery Devices - Pipeline Products by Stage of Under Development
      • Table Insulin Delivery Devices - Pipeline Products by Stage of Under Development
  • Insulin Delivery Devices Companies and Product Overview
    • Amrita Vishwa Vidyapeetham Company Overview
      • Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amrita Insulin Pump - Product Status
        • Table Amrita Insulin Pump - Product Description
    • Andain, Inc Company Overview
      • Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gaia Med Diamond Semi-Disposable Pump - Product Status
        • Table Gaia Med Diamond Semi-Disposable Pump - Product Description
        • Table Gemini Pump - Product Status
        • Table Gemini Pump - Product Description
    • Animas Corp Company Overview
      • Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hypoglycemia-Hyperglycemia Minimizer System - Product Status
        • Table Hypoglycemia-Hyperglycemia Minimizer System - Product Description
    • ASTI Corp Company Overview
      • ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical Microneedle System - Product Status
        • Table Medical Microneedle System - Product Description
    • Avecho Biotechnology Ltd Company Overview
      • Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TPM-Insulin Patch - Product Status
        • Table TPM-Insulin Patch - Product Description
    • Becton Dickinson and Co Company Overview
      • Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table BD Vystra Disposable Pen - Product Status
        • Table BD Vystra Disposable Pen - Product Description
        • Table Extended Wear Insulin Infusion Set - Product Status
        • Table Extended Wear Insulin Infusion Set - Product Description
        • Table Type 2 Patch Pump - Product Status
        • Table Type 2 Patch Pump - Product Description
    • Bigfoot Biomedical Inc Company Overview
      • Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bigfoot Inject - Product Status
        • Table Bigfoot Inject - Product Description
        • Table Smartloop Integrated With FreeStyle Libre Glucose Monitoring System - Product Status
        • Table Smartloop Integrated With FreeStyle Libre Glucose Monitoring System - Product Description
    • Biocon Ltd Company Overview
      • Biocon Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biocon Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Semglee Prefilled Pen - Product Status
        • Table Semglee Prefilled Pen - Product Description
    • Cam Med LLC Company Overview
      • Cam Med LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cam Med LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Evopump - Product Status
        • Table Evopump - Product Description
    • Cambridge Consultants Ltd Company Overview
      • Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table KiCoPen - Product Status
        • Table KiCoPen - Product Description
    • Capillary Biomedical, Inc. Company Overview
      • Capillary Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Capillary Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CSII Catheter - Product Status
        • Table CSII Catheter - Product Description
        • Table Capillary Biomedical, Inc. - Ongoing Clinical Trials Overview
        • Table CSII Catheter - A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue
    • Cellnovo Ltd Company Overview
      • Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wireless Insulin Pump System Integrated With inControl AP - Product Status
        • Table Wireless Insulin Pump System Integrated With inControl AP - Product Description
    • CeQur SA Company Overview
      • CeQur SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table CeQur SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table PAQ MEAL - Product Status
        • Table PAQ MEAL - Product Description
    • Companion Medical Inc Company Overview
      • Companion Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InPen System - Product Status
        • Table InPen System - Product Description
        • Table Companion Medical Inc - Ongoing Clinical Trials Overview
        • Table InPen System - CloudConnect: Predictive and Retrospective Clinical Decision Support for Chronic Disease Management
        • Table InPen System - Connected Pens for Diabetes Study
    • Dance Biopharm Inc Company Overview
      • Dance Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dance Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dance-501 - Product Status
        • Table Dance-501 - Product Description
    • Debiotech SA Company Overview
      • Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jewel Pump - Product Status
        • Table Jewel Pump - Product Description
        • Table JewelPUMP2 - Product Status
        • Table JewelPUMP2 - Product Description
    • Defymed SAS Company Overview
      • Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table ExOlin - Product Status
        • Table ExOlin - Product Description
    • Dermisonics Inc (Inactive) Company Overview
      • Dermisonics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dermisonics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table U-Strip - Product Status
        • Table U-Strip - Product Description
    • Eli Lilly and Co Company Overview
      • Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table AID System - Product Status
        • Table AID System - Product Description
        • Table AIR Insulin System - Product Status
        • Table AIR Insulin System - Product Description
        • Table Integrated Insulin Management System - Product Status
        • Table Integrated Insulin Management System - Product Description
    • Emperra GmbH E-Health Technologies Company Overview
      • Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table ESYSTA BT Pen - Product Status
        • Table ESYSTA BT Pen - Product Description
    • Hospira Inc Company Overview
      • Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Integrated Symbiq/EndoTool System - Product Status
        • Table Integrated Symbiq/EndoTool System - Product Description
    • Imagine Medical Device Inc. Company Overview
      • Imagine Medical Device Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imagine Medical Device Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulin Syringe - Product Status
        • Table Insulin Syringe - Product Description
    • InsuLenz Company Overview
      • InsuLenz Pipeline Products & Ongoing Clinical Trials Overview
        • Table InsuLenz Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Polymer Contact Lens - Product Status
        • Table Smart Polymer Contact Lens - Product Description
    • Insulet Corp Company Overview
      • Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table OmniPod - Humalog U200 - Product Status
        • Table OmniPod - Humalog U200 - Product Description
        • Table OmniPod - New Version - Product Status
        • Table OmniPod - New Version - Product Description
    • InsuLine Medical Ltd Company Overview
      • InsuLine Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table InsuLine Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table InsuPad - Product Status
        • Table InsuPad - Product Description
        • Table Long Acting Insulin Therapy Device - Product Status
        • Table Long Acting Insulin Therapy Device - Product Description
    • Iowa State University Company Overview
      • Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Feed Forward Insulin Delivery System - Product Status
        • Table Feed Forward Insulin Delivery System - Product Description
    • LifeScan Inc Company Overview
      • LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status
        • Table ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description
    • MannKind Corp Company Overview
      • MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table AFREZZA - Medtone Inhaler - Product Status
        • Table AFREZZA - Medtone Inhaler - Product Description
        • Table MannKind Corp - Ongoing Clinical Trials Overview
        • Table AFREZZA - Medtone Inhaler - A-One: A Randomized Controlled Trial Evaluating One Drop | Premium with Afrezza versus One Drop | Premium Alone
        • Table AFREZZA - Medtone Inhaler - Improving Post-prandial Blood Glucose Control with Afrezza During Closed-loop Therapy
        • Table AFREZZA - Medtone Inhaler - Initiating Mealtime Ultra-rapid Acting Insulin (Afrezza) in Uncontrolled Type II Diabetes Patients
        • Table AFREZZA - Medtone Inhaler - Open-label, Single-arm, Multiple-dose Safety, Titration, and Pharmacokinetic Trial of Afrezza in Pediatric Patients Ages 4 to 17 Years with Type 1 Diabetes Mellitus
        • Table AFREZZA - Medtone Inhaler - Study Comparing Prandial Insulin Aspart Vs. Technosphere Insulin in Patients with Type 1 Diabetes on Multiple Daily Injections: Investigator-initiated a Real-life Pilot Study-STAT Study
    • Medical International Technologies (Mit Canada) Inc Company Overview
      • Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Med-Jet MIT-P-I - Product Status
        • Table Med-Jet MIT-P-I - Product Description
    • MedPro Safety Products, Inc. Company Overview
      • MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulin Guard Self-Injector Safety Needle - Product Status
        • Table Insulin Guard Self-Injector Safety Needle - Product Description
    • MedSolve Technologies, Inc. Company Overview
      • MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Freehand Patch Pump - Product Status
        • Table Freehand Patch Pump - Product Description
    • Medtronic Diabetes Company Overview
      • Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulin Delivery System - Product Status
        • Table Insulin Delivery System - Product Description
        • Table MiniMed Mio Advance Infusion Set - Product Status
        • Table MiniMed Mio Advance Infusion Set - Product Description
    • Medtronic plc Company Overview
      • Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Gen Bluetooth-enabled MiniMed Pump - Product Status
        • Table Next Gen Bluetooth-enabled MiniMed Pump - Product Description
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Angel Touch - Product Status
        • Table Angel Touch - Product Description
        • Table La Fenice Pen - Product Status
        • Table La Fenice Pen - Product Description
        • Table La Fenice V - Product Status
        • Table La Fenice V - Product Description
    • NanoDerma Ltd Company Overview
      • NanoDerma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoDerma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intranasal Insulin Delivery Device - Product Status
        • Table Intranasal Insulin Delivery Device - Product Description
    • Nitto Denko Corp Company Overview
      • Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Status
        • Table PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Description
        • Table PassPort Transdermal Basal Insulin Patch - 24Hours - Product Status
        • Table PassPort Transdermal Basal Insulin Patch - 24Hours - Product Description
    • North Carolina State University Company Overview
      • North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pulsatile Noninvasive Drug Delivery System - Product Status
        • Table Pulsatile Noninvasive Drug Delivery System - Product Description
    • Novo Nordisk AS Company Overview
      • Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table AERx iDMS - Product Status
        • Table AERx iDMS - Product Description
        • Table Ingestible SOMA - Product Status
        • Table Ingestible SOMA - Product Description
    • Pennsylvania State University Company Overview
      • Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanobot Based Insulin Pumping Device - Product Status
        • Table Nanobot Based Insulin Pumping Device - Product Description
    • Phluid Corporation Company Overview
      • Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ambulatory Diabetes Pump - Product Status
        • Table Ambulatory Diabetes Pump - Product Description
    • Prometheon Pharma LLC Company Overview
      • Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table TruePatch - Basal Insulin - Product Status
        • Table TruePatch - Basal Insulin - Product Description
        • Table TruePatch - Rapid-Acting (Bolus) Insulin - Product Status
        • Table TruePatch - Rapid-Acting (Bolus) Insulin - Product Description
    • Sanofi Company Overview
      • Sanofi Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sanofi Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fix-Flex Device - Product Status
        • Table Fix-Flex Device - Product Description
    • SFC Fluidics LLC Company Overview
      • SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Disposable Insulin Patch Pump - Product Status
        • Table Disposable Insulin Patch Pump - Product Description
        • Table Dual ePump - Product Status
        • Table Dual ePump - Product Description
        • Table Pod Automated Insulin Delivery Device - Product Status
        • Table Pod Automated Insulin Delivery Device - Product Description
    • Spring Health Solutions Ltd. Company Overview
      • Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spring Zone Hybrid Patch Pump - Product Status
        • Table Spring Zone Hybrid Patch Pump - Product Description
    • Tandem Diabetes Care Inc Company Overview
      • Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table t:sport - Product Status
        • Table t:sport - Product Description
    • Terumo Corp Company Overview
      • Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulin Patch Pump - Product Status
        • Table Insulin Patch Pump - Product Description
    • Thermalin Inc Company Overview
      • Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulin Patch - Product Status
        • Table Insulin Patch - Product Description
        • Table Ultra Rapid Insulin Pump - Product Status
        • Table Ultra Rapid Insulin Pump - Product Description
        • Table Ultra-Concentrated Insulin Pump - Product Status
        • Table Ultra-Concentrated Insulin Pump - Product Description
    • Transdermal Specialties Inc Company Overview
      • Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table U-Strip Insulin Patch - Product Status
        • Table U-Strip Insulin Patch - Product Description
    • University of KwaZulu-Natal Company Overview
      • University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pectin Insulin Gel Skin Patch - Product Status
        • Table Pectin Insulin Gel Skin Patch - Product Description
    • University of Missouri-Kansas City Company Overview
      • University of Missouri-Kansas City Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Missouri-Kansas City Pipeline Products & Ongoing Clinical Trials Overview
        • Table Light Activated Insulin Depot - Product Status
        • Table Light Activated Insulin Depot - Product Description
    • University of North Carolina Company Overview
      • University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Cell Patch - Product Status
        • Table Smart Cell Patch - Product Description
        • Table Smart Insulin Patch - Product Status
        • Table Smart Insulin Patch - Product Description
    • University of Toronto Company Overview
      • University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Closed-Loop Insulin Delivery Device - Product Status
        • Table Implantable Closed-Loop Insulin Delivery Device - Product Description
    • Univlabs Technologies Pvt Ltd Company Overview
      • Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Univlabs Technologies Pvt Ltd Insulin Patch Pump - Product Status
        • Table Univlabs Technologies Pvt Ltd Insulin Patch Pump - Product Description
    • Valeritas Inc Company Overview
      • Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table V-Go Prefill Device - Product Status
        • Table V-Go Prefill Device - Product Description
        • Table V-Go SIM - Product Status
        • Table V-Go SIM - Product Description
        • Table V-Go Wearable Insulin Delivery Device - Product Status
        • Table V-Go Wearable Insulin Delivery Device - Product Description
        • Table Valeritas Inc - Ongoing Clinical Trials Overview
        • Table V-Go Wearable Insulin Delivery Device - Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go in Patients with Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices: TITRATE
        • Table V-Go Wearable Insulin Delivery Device - Efficacy and Safety Comparison Between U-100 Regular Human Insulin and Rapid Acting Insulin When Delivered by VGo Wearable Insulin Delivery in Type 2 Diabetes
    • ViCentra BV Company Overview
      • ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kaleido Insulin Pump - Product Status
        • Table Kaleido Insulin Pump - Product Description
    • Vigmed Holding AB Company Overview
      • Vigmed Holding AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vigmed Holding AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulin Needles - Product Status
        • Table Insulin Needles - Product Description
    • WaveForm Technologies Inc Company Overview
      • WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Closed Loop Insulin Delivery Solution - Product Status
        • Table Closed Loop Insulin Delivery Solution - Product Description
    • Ypsomed Holding AG Company Overview
      • Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lanzi - Product Status
        • Table Lanzi - Product Description
        • Table mylife YpsoPod Insulin Pump - Tubeless - Product Status
        • Table mylife YpsoPod Insulin Pump - Tubeless - Product Description
        • Table mylife YpsoPump - Product Status
        • Table mylife YpsoPump - Product Description
    • Zealand Pharma AS Company Overview
      • Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table HypoPal Rescue Pen - Product Status
        • Table HypoPal Rescue Pen - Product Description
        • Table Zealand Pharma AS - Ongoing Clinical Trials Overview
        • Table HypoPal Rescue Pen - Phase 3, Randomized, Double-blind, Placebo/Active-controlled, Parallelarm Trial to Assess Efficacy, Safety, and Pharmacokinetics of Dasiglucagon Relative to Placebo/GlucaGen as Rescue Therapy for Severe Hypoglycemia in Children with T1DM Treated with Insulin
  • Insulin Delivery Devices - Recent Developments
    • Jun 25, 2019: ConvaTec Group: Board Change
    • Jun 17, 2019: Xeris Pharmaceuticals announces additional positive outcomes from a global phase 3 clinical trial of its investigational ready-to-use glucagon
    • Jun 17, 2019: BD announces new leadership for BD Biosciences
    • Jun 14, 2019: Biocon Biologics facilities In Bengaluru receive EU GMP Certification
    • Jun 14, 2019: Drug Makers Sue to Block requirement for Listing Prices in TV Ads
    • Jun 11, 2019: Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA)
    • Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee
    • Jun 11, 2019: Regulators demand more details on Roche's $4.8bn Spark acquisition
    • Jun 10, 2019: Valeritas V-Go Wearable Insulin Delivery Device demonstrates a reduction in A1c levels by 1.3 when intensifying from a basal insulin regimen to basal-bolus delivery
    • Jun 09, 2019: MannKind Presents Positive Afrezza Clinical Data from Three Studies at ADA 79th Scientific Sessions
    • Jun 07, 2019: Companion Medical announces product updates to support data partnerships and enhanced reporting
    • Jun 07, 2019: Paul Hudson to succeed Olivier Brandicourt as chief executive officer
    • Jun 06, 2019: Dexcom and Companion Medical announce collaboration to integrate Dexcom CGM data and InPen insulin data
    • Jun 06, 2019: Insulet to showcase its recently-lunched Omnipod DASH System and present seven scientific abstracts at the American Diabetes Association's 79th Scientific Sessions
    • Jun 05, 2019: CeQur appoints Bradley Paddock Chief Executive Officer
    • Jun 05, 2019: Companion Medical and Glooko announce partnership agreement to integrate insulin data for multiple daily injections
    • Jun 05, 2019: Jeff Settleman, Ph.D., joins Pfizer to lead oncology research & development
    • Jun 04, 2019: Rimidi and Companion Medical announce first U.S. partnership to bring connected Insulin data Into the clinical workflow
    • Jun 04, 2019: Medtronic awarded $150M contract from Defense Logistics Agency
    • Jun 03, 2019: Afrezza (insulin human) inhalation powder approved in Brazil
    • May 29, 2019: Valeritas to participate in the American Diabetes Association's 79th Scientific Sessions; company reiterates second quarter and full-year 2019 revenue guidance
    • May 28, 2019: American Diabetes Association Includes "Disposable Patch-Like Device," such as V-Go from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019
    • May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation
    • May 24, 2019: Phosphagenics: Change of company name and ASX code
    • May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
    • May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability
    • May 22, 2019: Valeritas' V-Go demonstrates positive impact in diabetes quality performance measures in an older adult population
    • May 22, 2019: Lilly's lower-priced Insulin now available
    • May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research
    • May 20, 2019: ViCentra accelerates international expansion with appointment of new CEO
    • May 20, 2019: LifeScan Names Ty Lee Head of Marketing
    • May 16, 2019: MannKind announces Afrezza Distribution Agreement in Australia
    • May 16, 2019: 'Smart' insulin could prevent hypoglycemia during diabetes treatment
    • May 15, 2019: Johnson & Johnson outlines strategy to deliver above-market growth at 2019 pharmaceutical business review
    • May 15, 2019: Retractable Technologies announces results as of March 31, 2019
    • May 09, 2019: Thirdwayv's SecureConnectivity Solution included in commercial deployment in the healthcare device market
    • May 09, 2019: Dance Biopharm appoints Kenneth B. Lee, Jr. to board of directors
    • May 09, 2019: BD announces results for 2019 second fiscal quarter; updates fiscal 2019 guidance
    • May 09, 2019: Valeritas announces first quarter 2019 financial results and updates full year 2019 revenue guidance
    • May 09, 2019: Cellnovo announces the initiation of compulsory liquidation proceedings with cessation of business
    • May 09, 2019: DECN sets plan to make upcoming patent infringement appeal hearing and mediation with Johnson & Johnson a foundation for substantial recovery
    • May 08, 2019: Nektar Therapeutics reports financial results for the first quarter of 2019
    • May 07, 2019: MannKind reports 2019 first quarter financial results
    • May 07, 2019: Retractable Technologies reports settlement of all existing litigation
    • May 03, 2019: Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019
    • May 02, 2019: Antares Pharma reports first quarter 2019 operating and financial results
    • May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
    • May 02, 2019: Integer Holdings reports first quarter 2019 results
    • May 02, 2019: Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year
    • May 02, 2019: Major life sciences and healthcare companies join Chronicled's MediLedger Project working group
    • May 02, 2019: Valeritas expects first quarter revenue of $6.4 million
    • Apr 30, 2019: Pfizer reports first-quarter 2019 results
    • Apr 30, 2019: Lilly reports solid first-quarter 2019 financial results, updates 2019 guidance to reflect disposition of Elanco animal health
    • Apr 30, 2019: Tandem Diabetes Care announces first quarter 2019 financial results and updated 2019 financial guidance
    • Apr 30, 2019: Novo Nordisk to achieve target of 100% renewable power in production and launches new ambition aiming for zero environmental impact
    • Apr 29, 2019: ViCentra announces Kaleido launch in UK
    • Apr 26, 2019: Valeritas' V-Go Wearable Insulin Delivery Device demonstrates a reduction in A1c levels by 1.5 and total daily insulin dosage by 14%
    • Apr 26, 2019: Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
    • Apr 26, 2019: AstraZeneca: Q1 2019 results
    • Apr 26, 2019: Nationally recognized expert in consumerism joins Henry Ford Health System
    • Apr 25, 2019: Bayer: strong operational start to the year
    • Apr 25, 2019: Biocon Q4FY19 Revenue Rs 1,557 Cr, Up 26%; EBITDA Up 43% at Rs 431 Cr; Net Profit Up 64% at Rs 214 Cr
    • Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018
    • Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year
    • Apr 17, 2019: Abbott reports first-quarter 2019 results
    • Apr 16, 2019: Ginkgo Bioworks appoints former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors
    • Apr 16, 2019: Johnson & Johnson reports 2019 first-quarter results
    • Apr 11, 2019: Companion Medical Announces Expansion of Commercial Operations
    • Apr 10, 2019: Sanofi provides unprecedented access to its insulins for one set monthly price
    • Apr 09, 2019: Diabeloop and ViCentra announce European distribution partnership
    • Apr 09, 2019: Henry Ford Health System names two new senior leaders
    • Apr 08, 2019: Valeritas' V-Go Wearable Insulin Delivery Device demonstrates 24% reduction in total daily insulin dosage and lower A1C compared to standard insulin treatment
    • Apr 08, 2019: LifeScan names Brian Heald as its new Head of Product
    • Apr 04, 2019: Pharma firm Bayer hit with WINNTI malware
    • Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer
    • Mar 29, 2019: Retractable Technologies announces Results for the Year 2018
    • Mar 28, 2019: Valeritas announces V-Go distribution agreement in Israel
    • Mar 28, 2019: MicroPort announces annual results for 2018
    • Mar 28, 2019: Cellnovo stops manufacturing and commercial operations
    • Mar 27, 2019: Phosphagenics: Changes to leadership team
    • Mar 27, 2019: AstraZeneca leads in the development of a new International Life Science Innovation Park in China
    • Mar 26, 2019: Cellnovo announces the initiation of collective proceedings regarding its UK subsidiary and requests the opening of conciliation proceedings in France
    • Mar 26, 2019: AstraZeneca slash almost 100 jobs in manufacturing 'hammer blow'
    • Mar 25, 2019: ConvaTec Group names Karim Bitar as Chief Executive Officer
    • Mar 23, 2019: New hybrid closed loop insulin pump proves hard to use for some patients with diabetes
    • Mar 22, 2019: Smiths announces its plans for the separation of Smiths Medical
    • Mar 21, 2019: Cellnovo issues an update on its commercial activity and financial situation
    • Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips
    • Mar 19, 2019: Abbott introduces new digital service in India as part of its global a:care program
    • Mar 18, 2019: CeQur appoints Peter B. Luther to Board of Directors
    • Mar 14, 2019: Medtronic names Andrea J. Goldsmith as a new director
    • Mar 14, 2019: AstraZeneca: Appointment of M s. Sarah Wang as an additional director
    • Mar 07, 2019: Tandem Diabetes Care approved as insulin pump vendor for ADP in Ontario, Canada
    • Mar 06, 2019: Tandem Diabetes Care announces plan to use remote software update tool in ongoing clinical trial
    • Mar 05, 2019: Valeritas announces fourth quarter and full year 2018 financial results
    • Mar 04, 2019: Antares Pharma announces board changes
    • Mar 01, 2019: ViCentra and Bosman renew distribution agreement for Kaleido in the Netherlands
    • Mar 01, 2019: Biocon appoints Christiane Hamacher as the CEO of Biocon Biologics Ltd
    • Mar 01, 2019: Pius S. Hornstein, PhD, appointed new country chair of Sanofi China
    • Feb 28, 2019: Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
    • Feb 28, 2019: Nektar Therapeutics reports fourth quarter and year-end 2018 financial results
    • Feb 26, 2019: Tandem Diabetes Care announces succession plan for chief executive officer and board of directors
    • Feb 26, 2019: Tandem Diabetes Care announces 2018 financial results and 2019 financial guidance
    • Feb 25, 2019: Midatech Pharma: Board changes
    • Feb 25, 2019: Insulet announces fourth quarter 2018 revenue of $164.9 million, up 26% year-over-year, and full year 2018 revenue of $563.8 million, up 22%
    • Feb 22, 2019: Abbott planning $62M expansion in Columbus, adding 38 jobs
    • Feb 21, 2019: Switching to Valeritas' V-Go Wearable Insulin Delivery Device from Insulin Pen Devices for Basal-Bolus Therapy improved glycemic control with less insulin
    • Feb 21, 2019: Integer Holdings reports results for fourth quarter and full year 2018
    • Feb 20, 2019: MannKind presents new scientific data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)
    • Feb 20, 2019: Tandem Diabetes Care appoints new senior vice president to drive expansion of digital health and information technology initiatives
    • Feb 19, 2019: Accu-Chek Insight insulin pumps - some need to be fitted with key frames to reduce the risk of accidentally unlocking keys or pressing the bolus buttons
    • Feb 19, 2019: Medtronic reports third quarter financial results
    • Feb 18, 2019: Cellnovo expands its base of potential users
    • Feb 18, 2019: Biocon facilities complete Pre approval U.S.FDA inspection
    • Feb 15, 2019: FDA clears Tandem Diabetes' t:Slim X2 insulin pump
    • Feb 15, 2019: Bristol pharmaceutical company Avara Avlon Pharma collapses putting 270 jobs at risk
    • Feb 15, 2019: Aradigm announces plans for reorganization under Chapter 11 of the U.S. Bankruptcy Code
    • Feb 14, 2019: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
    • Feb 14, 2019: AstraZeneca announces full-year and Q4 2018 results
    • Feb 14, 2019: ConvaTec Group fourth quarter and annual results 2018
    • Feb 12, 2019: Insulet's president and CEO Shacey Petrovic to participate in keynote interview at Device Talks Boston 2019
    • Feb 12, 2019: Sanofi names Ameet Nathwani as chief digital officer
    • Feb 08, 2019: Johnson & Johnson to disclose drug prices in television ads
    • Feb 07, 2019: New pill can deliver insulin
    • Feb 07, 2019: Sanofi delivers 2018 business EPS growth of 5.1% at CER
    • Feb 06, 2019: Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director
    • Feb 06, 2019: Lilly reports strong fourth-quarter and full-year 2018 financial results, lowers 2019 EPS guidance to reflect the pending acquisition of loxo oncology
    • Feb 05, 2019: BD announces results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
    • Feb 04, 2019: JDRF statement On United Healthcare insulin pump agreement with Medtronic
    • Feb 01, 2019: Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
    • Feb 01, 2019: Pfizer staff set to strike in dispute over pensions
    • Feb 01, 2019: Smiths Medical issues a voluntary nationwide recall of sterile water and saline for inhalation USP products
    • Jan 31, 2019: Roche reports very strong results in 2018
    • Jan 28, 2019: Insulet names Corinne Nevinny as board director
    • Jan 25, 2019: Companion Medical announces launch of the InPen System for Android
    • Jan 25, 2019: Data from multiple studies demonstrate CeQur PAQ Basal-Bolus Insulin Delivery Device is a successful alternative to multiple daily Insulin Injections
    • Jan 24, 2019: BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
    • Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
    • Jan 24, 2019: Biocon Q 3 FY19 earnings revenue at Rs 1,566 Cr, up 43 %; net profit at Rs 217 Cr, up 136% EBITDA at Rs 406 Cr, up 59 %
    • Jan 24, 2019: Medochemie & Pfizer partner in Vietnam
    • Jan 23, 2019: Sanofi joins Startup Creasphere - Munich's first digital health focused innovation program\
    • Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019
    • Jan 23, 2019: Up to 900 Pfizer staff to ballot for industrial action
    • Jan 22, 2019: Johnson & Johnson reports 2018 fourth-quarter results
    • Jan 17, 2019: BD announces preliminary results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
    • Jan 16, 2019: MannKind announces direct purchase insulin program providing Afrezza for as low as $4 a Day
    • Jan 16, 2019: Dance Biopharm Strengthens Leadership Team to Advance Late-Stage Diabetes Development Program and Transition Pipeline Candidates into Clinical Trials
    • Jan 15, 2019: Cellnovo announces its Q4 and full year 2018 sales
    • Jan 14, 2019: Valeritas announces V-Go received preferred status on OptumRx Formularies
    • Jan 14, 2019: Poseidon and Nanopump presented at Pharmapack 2019 in Paris
    • Jan 11, 2019: Pre-quarterly results communication
    • Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
    • Jan 09, 2019: AstraZeneca laying off 200-plus in Boulder, Longmont
    • Jan 08, 2019: Pfizer to exit two more plants in India
    • Jan 07, 2019: AstraZeneca announces organisational changes
    • Jan 07, 2019: Insulet names Wayde McMillan as Chief Financial Officer
    • Jan 07, 2019: Aptamer Group and AstraZeneca sign agreement to explore feasibility of developing drug delivery vehicles
    • Jan 03, 2019: Valeritas announces V-Go is preferred on Humana Part D Formularies
    • Jan 03, 2019: Dance Biopharm Achieves Growth and Organizational Milestones in 2018 with Continued Development of Inhaled Biologics Pipeline
    • Jan 03, 2019: Tandem Diabetes Care announces appointment of Rebecca Robertson as board member
    • Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager
    • Jan 02, 2019: Terumo announces global expansion into Canadian market - opens 58,000 square foot facility in Vaughan, Ontario
    • Dec 26, 2018: Mr. Noboru Shimizu joined MicroPort CRM as Vice-President, Country Manager Japan, and Head of Commercial Operations of MicroPort CRM Japan
    • Dec 24, 2018: Phosphagenics: Resignation and appointment of joint company secretaries and chief financial officer
    • Dec 20, 2018: Health Canada releases action plan on medical devices
    • Dec 19, 2018: Lilly announces financial guidance, reviews commercial performance, and highlights promising pipeline opportunities at Investment Community Meeting
    • Dec 18, 2018: Insulet to present at the 37th Annual J.P. Morgan Healthcare Conference
    • Dec 18, 2018: Sanofi to transfer U.S. stock exchange listing to Nasdaq
    • Dec 18, 2018: Sanofi moving 2,700 staffers from the Boston suburbs to Cambridge crossing
    • Dec 17, 2018: Biocon's APIs manufacturing facility in Telangana completes U.S. FDA inspection with No 483 observations
    • Dec 14, 2018: AstraZeneca: Non-executive Board changes
    • Dec 13, 2018: Sanofi's formulation patents on multibillion-dollar Lantus are invalidated by U.S. Patent and Trademark Office via IPR, announces Mylan
    • Dec 13, 2018: Antares Pharma names Peter S. Greenleaf to company's Board of Directors
    • Dec 12, 2018: Julphar to launch Wearable Insulin Delivery Device in GCC
    • Dec 10, 2018: New member proposed for election to Roche Board of Directors
    • Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine
    • Dec 10, 2018: Roche names William Anderson as CEO
    • Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019
    • Dec 07, 2018: FORA Diamond MINI Blood Glucose Monitor provides seamless connection with the Cellnovo System, the first connected Diabetes Management Platform
    • Dec 06, 2018: Aerogen wins fifth Zenith award for respiratory care excellence from AARC
    • Dec 05, 2018: Bayer lays out new strategy and growth ambitions
    • Dec 05, 2018: Bayer to drive value creation as company pursues ambitious growth targets through 2022
    • Dec 05, 2018: Sanofi plans 670 job cuts in France by end 2020
    • Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent
    • Dec 03, 2018: Johnston County commissioners approve incentives for latest Novo Nordisk expansion
    • Dec 03, 2018: Defymed - Winner of the first Innovation Prize
    • Nov 29, 2018: Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability
    • Nov 27, 2018: MannKind names Christine Mundkur as Board Director
    • Nov 26, 2018: Study supports Valeritas V-Go can improve glycemic control in type 2 patients when using an easy to follow physician-driven insulin titration algorithm
    • Nov 26, 2018: Henry Ford Health System announced Dr. Betty Chu appointments
    • Nov 23, 2018: FORA Blood Glucose Monitor Provides Seamless integration with new Cellnovo Insulin Pump and Handset
    • Nov 20, 2018: Insulet's Omnipod DASH Insulin Management System receives ISO 27001 Certification for Information Security
    • Nov 20, 2018: Medtronic reports financial results of second quarter of fiscal year 2019
    • Nov 19, 2018: Pfizer provides transparency on drug prices in the U.S; 90 percent of company's prices will remain unchanged
    • Nov 15, 2018: Smiths Group to spin off medical devices unit
    • Nov 15, 2018: Retractable Technologies announces results as of September 30, 2018
    • Nov 14, 2018: Nektar appoints Wei Lin, M.D., as Senior Vice President of clinical development and Head of Nektar's oncology programs
    • Nov 13, 2018: Bayer: Good performance in a challenging environment, group outlook confirmed
    • Nov 12, 2018: Valeritas' V-Go wearable insulin delivery device demonstrated improved clinical and economic benefits across established BMI strata in patients with type 2 diabetes including those overweight and obese
    • Nov 09, 2018: Valeritas reports record revenue for the third quarter 2018
    • Nov 08, 2018: AstraZeneca: Year-to-date and Q3 2018 results
    • Nov 08, 2018: Medtronic delivers significant progress on global corporate citizenship efforts
    • Nov 07, 2018: LifeScan unveils new name and branding for the LifeScan Diabetes Institute
    • Nov 07, 2018: Nektar Therapeutics reports financial results for the third quarter of 2018
    • Nov 06, 2018: BD announces results for 2018 fourth fiscal quarter and full year; provides fiscal 2019 guidance
    • Nov 06, 2018: Lilly delivers solid third-quarter 2018 results, revises EPS guidance
    • Nov 06, 2018: Ypsomed grows strongly with own products
    • Nov 01, 2018: Novo Nordisk's operating profit decreased by 6% in Danish kroner and increased by 2% in local currencies in the first nine months of 2018
    • Nov 01, 2018: MannKind reports 2018 third quarter financial results
    • Nov 01, 2018: Insulet reports third quarter 2018 revenue of $151.1 million, up 24% yearover- year, and gross margin over 67%, up 700 basis points
    • Nov 01, 2018: Tandem Diabetes Care reports third quarter 2018 financial results
    • Nov 01, 2018: Integer Holdings Reports Third Quarter 2018 Results
    • Oct 31, 2018: Sanofi Q3 2018 performance confirms return to growth
    • Oct 30, 2018: Pfizer reports third quarter 2018 results
    • Oct 29, 2018: Cellnovo expands international distribution network with first agreement in South America
    • Oct 25, 2018: Biocon announces financial results for the second quarter ended on September 30th, 2018
    • Oct 22, 2018: Experts from Pakistan Society of Interventional Cardiology visits MicroPort
    • Oct 19, 2018: Valeritas announces that V-Go Insulin Delivery Device has launched in Italy
    • Oct 18, 2018: Anna Maria Braun to succeed Heinz-Walter Grobe as chairman of the management board of B. Braun Melsungen in April 2019
    • Oct 17, 2018: Roche reports very strong growth in the first nine months of 2018
    • Oct 17, 2018: Roche reports sales growth as new drugs ease pressure from biosimilar competition
    • Oct 17, 2018: Abbott Reports Third-Quarter 2018 Results
    • Oct 17, 2018: Bayer provides disaster relief Immediate support for earthquake victims in Indonesia company makes EUR 115,000 available in immediate assistance for people impacted in Central Sulawesi province
    • Oct 17, 2018: Aerogen announce expansion plans for Galway
    • Oct 16, 2018: Eli Lilly and Company names Karen Walker as Board of Directors
    • Oct 16, 2018: Johnson & Johnson reports 2018 third-quarter results
    • Oct 15, 2018: Sanofi Genyzme seeks up to 400,000 square feet in Cambridge
    • Oct 15, 2018: Novo Nordisk names Ludovic Helfgott executive vice president Biopharm
    • Oct 15, 2018: Abbott names Robert B. Ford President, Chief Operating Officer
    • Oct 15, 2018: ConvaTec Group announces retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)
    • Oct 12, 2018: Fiasp is effective at controlling blood sugar levels in children and adolescents living with type 1 diabetes, when compared to conventional insulin aspart
    • Oct 12, 2018: Tandem Diabetes Care receives Health Canada approval to market t:slim X2 Insulin Pump
    • Oct 09, 2018: Astrazeneca sues block Zydus Cadila bid generic nexium
    • Oct 09, 2018: Pfizer announces Executive Leadership Team
    • Oct 08, 2018: Solara announces additions to management team and board of directors
    • Oct 04, 2018: MannKind Presents Positive Afrezza STAT Study Clinical Data at 54th Annual Meeting of the European Association for the Study of Diabetes
    • Oct 03, 2018: Novo Nordisk signs three deals to advance new insulin pens
    • Oct 03, 2018: MannKind presents new scientific data at 54th Annual Meeting of the European Association for the Study of Diabetes
    • Oct 03, 2018: J&J concludes sale of LifeScan to Platinum Equity for $2.1bn
    • Oct 02, 2018: Valeritas V-Go demonstrates benefits versus multiple daily injections in patients with type 2 diabetes
    • Oct 02, 2018: Aerogen open new offices in Beijing
    • Oct 01, 2018: Health Canada approves TRESIBA for children with Type 1 diabetes
    • Oct 01, 2018: Pfizer announces CEO succession
    • Sep 27, 2018: Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
    • Sep 27, 2018: Bayer appoints Sebastian Guth to lead Pharmaceuticals business in the Americas
    • Sep 27, 2018: Midatech Pharma: Interim results for the six months ended 30 June 2018
    • Sep 26, 2018: Valeritas Begins Medical Device Registration Process in China for Its VGo Wearable Insulin Delivery Device
    • Sep 25, 2018: Analysis Demonstrates CeQur PAQ Insulin Delivery Device is Highly Cost Effective for People with Type 2 Diabetes Not in Glycemic Control
    • Sep 23, 2018: Bayer expands facility
    • Sep 22, 2018: Biocon's drug substance facility in Bangalore completes US FDA inspection with No observations
    • Sep 21, 2018: Ontario becomes first province to provide public funding of TRESIBA for adults with diabetes mellitus
    • Sep 20, 2018: SFC Fluidics receives SBIR phase II funding to develop a dual hormone patch pump for patients with diabetes
    • Sep 20, 2018: Novo Nordisk to lay off 400 employees in Denmark and China
    • Sep 19, 2018: Opening ceremony of a full cycle production facility at Novo Nordisk plant, Grabtsevo Industrial Park
    • Sep 13, 2018: Positive Afrezza clinical data from STAT Study published in Diabetes Technology & Therapeutics
    • Sep 13, 2018: Sanofi to refocus two global business units
    • Sep 13, 2018: Bayer appointed Stefan Oelrich to Board of Management
    • Sep 13, 2018: Elixir Technologies granted HITRUST certification
    • Sep 13, 2018: Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the tenth year running
    • Sep 13, 2018: Abbott is named global industry leader in sustainability for the sixth consecutive year on the Dow Jones Sustainability Index (DJSI)
    • Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018
    • Sep 06, 2018: AstraZeneca: Directorate change
    • Sep 04, 2018: Phosphagenics receives arbitration update from SIAC
    • Sep 01, 2018: Nektar Therapeutics strengthens Board of Directors with appointment of Veteran Biotechnology Executive Karin Eastham
    • Aug 30, 2018: MicroPort CRM announces change in strategic direction for Japan CRM market and end of distribution agreement with JLL in One Year's Time
    • Aug 28, 2018: Changes to the Roche Executive Committee
    • Aug 26, 2018: Julphar signs agreement with BD to supply disposable Insulin Pens in UAE
    • Aug 24, 2018: Cadila Healthcare's Biologics manufacturing facility successfully completes USFDA inspection
    • Aug 23, 2018: Valeritas announces that V-Go Insulin Delivery Device has launched in Australia
    • Aug 21, 2018: Medtronic announces first quarter financial results
    • Aug 17, 2018: Tandem Diabetes Care announces commercial launch of t:slim X2 Insulin Pump with Basal-IQ technology in the United States
    • Aug 16, 2018: Insulet to showcase Its Omnipod DASH Insulin Management System at the American Association of Diabetes Educators annual conference
    • Aug 16, 2018: Companion Medical and One Drop announce partnership in integrated diabetes management
    • Aug 16, 2018: BD elects Jeffrey Henderson to board of directors
    • Aug 15, 2018: Sime DX announces new design for lung maturity diagnostic device
    • Aug 14, 2018: Retractable Technologies announces June 30, 2018 financial results
    • Aug 14, 2018: Aradigm announces second quarter 2018 financial results
    • Aug 14, 2018: DECN Announces Significant Updates For Products And Programs
    • Aug 08, 2018: Tandem Diabetes Care announces publication of PROLOG study results in Diabetes Care Journal
    • Aug 08, 2018: Novo Nordisk's operating profit decreased by 8% in danish kroner and increased by 4% in local currencies in the first six months of 2018
    • Aug 08, 2018: Nektar Therapeutics reports financial results for the second quarter of 2018
    • Aug 07, 2018: Antares Pharma Reports Second Quarter 2018 Operating and Financial Results
    • Aug 07, 2018: Valeritas reports record second quarter revenue with 36% year-overyear growth
    • Aug 06, 2018: Valeritas announces V-Go distribution agreement in Czech Republic and Slovakia
    • Aug 06, 2018: Antares Pharma names Dr. James Tursi executive vice president, head of research & development, chief medical officer
    • Aug 02, 2018: Valeritas' V-Go Wearable Insulin Delivery Device Demonstrated Improved Clinical Benefits in Patients with Uncontrolled Type 2 Diabetes Previously Treated with Multiple Daily Injections
    • Aug 02, 2018: BD announces results for 2018 third fiscal quarter; raises fiscal 2018 revenue guidance
    • Aug 02, 2018: Insulet Reports second quarter 2018 revenue of $124.3 million, up 13% year-over-year, and gross margin of 66%, up 710 basis points
    • Aug 02, 2018: Integer Holdings reports second quarter 2018 results
    • Aug 02, 2018: ConvaTec Group First Half Results 2018
    • Aug 02, 2018: MannKind Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET
    • Aug 01, 2018: Valeritas announces that V-Go Insulin Delivery is now available in New Zealand
    • Aug 01, 2018: AstraZeneca faces US DOJ probe for alleged funding of Iraqi terrorists
    • Aug 01, 2018: BD appoints Simon Campion to Interventional Segment President
    • Aug 01, 2018: Medtronic announces Paurvi Bhatt as president of Medtronic Foundation
    • Aug 01, 2018: Global Healthcare Organizations join Abbott to launch the UNIVANTS of Healthcare Excellence Award
    • Jul 31, 2018: Pfizer reports second-quarter 2018 results
    • Jul 30, 2018: SFC Fluidics announces partnership with JDRF to develop Patch Pump with open-protocol communication
    • Jul 30, 2018: Tandem Diabetes Care Reports Second Quarter 2018 Financial Results
    • Jul 26, 2018: Roche reports very strong performance in the first half of 2018
    • Jul 26, 2018: AstraZeneca announces H1 2018 results
    • Jul 26, 2018: Sanofi Head of Human Resources Roberto Pucci to retire; Company names Caroline Luscombe to take over October 1st
    • Jul 26, 2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr
    • Jul 25, 2018: Valeritas, makers of V-Go Insulin Delivery, is a contributing supporter of the interactive insulin workshop at two MEDS Conferences
    • Jul 25, 2018: Midatech Pharma: Trading update
    • Jul 24, 2018: Lilly Delivers Strong Second-Quarter 2018 Results, Revises EPS Guidance
    • Jul 24, 2018: Pfizer to build $465m injectable medicines facility in US
    • Jul 23, 2018: Roche receives CE Mark for its Accu-Chek Solo micropump system
    • Jul 19, 2018: Companion Medical Announces CE Mark of InPen System
    • Jul 19, 2018: Synteract augments executive team with Cheryl Murphy as senior vice president, clinical development
    • Jul 18, 2018: Abbott reports second-Quarter 2018 Results
    • Jul 17, 2018: Johnson & Johnson Reports 2018 Second-Quarter Results
    • Jul 16, 2018: Defymed wins MedFIT 2018 Start-up slams
    • Jul 12, 2018: Personnel Changes in Supervisory and Management Board of Aesculap
    • Jul 11, 2018: Pfizer to Organize for Future Growth
    • Jul 10, 2018: Secretary Azar Statement Regarding Pfizer's Drug Pricing Announcement
    • Jul 10, 2018: Pfizer's announces it will defer company's price increases
    • Jul 09, 2018: Companion Medical Announces FDA Clearance for the InPen System for Android
    • Jul 06, 2018: Shanghai MicroPort Medical (Group) Won a Patent Right Lawsuit Against NewMed Medical
    • Jul 06, 2018: Aradigm Names Dr. Theresa Matkovits As Board Director
    • Jul 04, 2018: Biocon's Sterile Drug Product facility Receives EU GMP Certification
    • Jul 03, 2018: Omnipod Insulin Management System Now the Preferred Insulin Pump in British Columbia, Canada
    • Jul 03, 2018: It's official: No age restrictions on insulin pumps
    • Jul 03, 2018: ConvaTec Group Announces Changes in Board
    • Jul 02, 2018: Insulet Assumes Direct Operations of its Omnipod Insulin Management System Product Line in Europe
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report